ArticleCell reports2018
Repurposing Pan-HDAC Inhibitors for ARID1A-Mutated Ovarian Cancer.
Takeshi Fukumoto et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
70 papers cite itlatest 60 shown
this papercites it
ArticleCell reports2018
Takeshi Fukumoto et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.